Chinese Journal of Antituberculosis ›› 2018, Vol. 40 ›› Issue (11): 1152-1158.doi: 10.3969/j.issn.1000-6621.2018.11.002
• Original Articles • Previous Articles Next Articles
WANG Yu-xuan,WANG Chong,DONG Yu-jie,DU Wei-li,SONG Jing,LIU Zi-chen,LI Kun,LIU Shu-ku(),CHE Nan-ying(
)
Received:
2018-08-22
Online:
2018-11-10
Published:
2018-12-04
Contact:
Shu-ku LIU,Nan-ying CHE
E-mail:liushuku@aliyun.com;cheny0448@163.com
WANG Yu-xuan,WANG Chong,DONG Yu-jie,DU Wei-li,SONG Jing,LIU Zi-chen,LI Kun,LIU Shu-ku,CHE Nan-ying. Characteristics of the microbiome in lung tissue of patients with pulmonary tuberculosis[J]. Chinese Journal of Antituberculosis, 2018, 40(11): 1152-1158. doi: 10.3969/j.issn.1000-6621.2018.11.002
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2018.11.002
微生物 | 坏死区 | 肉芽肿区 | 正常肺区 |
---|---|---|---|
Ochrobactrum | 50.70±6.76 | 56.18±7.50 | 61.31±7.95 |
Sphingomonas | 7.50±2.07 | 7.69±1.29 | 3.81±2.08 |
Corynebacterium | 5.39±2.39 | 5.23±1.39 | 7.43±3.56 |
Brevundimonas | 1.67±0.42 | 1.75±0.67 | 2.09±0.34 |
Brevibacterium | 2.38±2.23 | 2.60±2.60 | 2.29±0.64 |
Sphingobacterium | 0.72±0.31 | 0.78±0.26 | 1.20±0.38 |
Enhydrobacter | 1.25±1.28 | 0.31±0.19 | 0.67±0.80 |
Kocuria | 0.06±0.05 | 0.02±0.02 | 0 |
Tsukamurella | 0.29±0.11 | 0.41±0.12 | 0.56±0.18 |
Mycobacterium | 0.81±1.92 | 0.01±0.01 | 0.01±0.02 |
微生物 | 坏死区 | 肉芽肿区 | 正常肺区 |
---|---|---|---|
Ochrobactrum | 50.70±6.76 | 57.80±7.88 | 63.00±6.55 |
Sphingomonas | 7.50±2.07 | 7.60±1.29 | 3.16±0.83 |
Corynebacterium | 5.39±2.39 | 5.05±1.50 | 7.78±3.63 |
Brevundimonas | 1.67±0.42 | 1.77±0.76 | 2.17±0.25 |
Brevibacterium | 2.38±2.23 | 2.41±2.80 | 2.25±0.67 |
Sphingobacterium | 0.72±0.31 | 0.70±0.20 | 1.21±0.40 |
Enhydrobacter | 1.25±1.28 | 0.31±0.21 | 0.71±0.85 |
Kocuria | 0.06±0.05 | 0.02±0.02 | 0 |
Tsukamurella | 0.29±0.11 | 0.39±0.13 | 0.57±0.18 |
Mycobacterium | 0.81±1.92 | 0.01±0.01 | 0.01±0.02 |
[1] |
Morris A, Beck JM, Schloss PD , et al. Comparison of the respiratory microbiome in healthy nonsmokers and smokers. Am J Respir Crit Care Med, 2013,187(10):1067-1075.
doi: 10.1164/rccm.201210-1913OC URL pmid: 23491408 |
[2] |
Bassis CM, Erb-Downward JR, Dickson RP , et al. Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals. Mbio, 2015,6(2):e00037.
doi: 10.1128/mBio.00037-15 URL pmid: 25736890 |
[3] |
Dickson RP, Erb-Downward JR, Freeman CM , et al. Bacterial Topography of the Healthy Human Lower Respiratory Tract. Mbio, 2017, 8(1). pii:e02287-16.
doi: 10.1128/mBio.02287-16 URL pmid: 28196961 |
[4] |
Einarsson GG, Comer DM, Mcllreavey L , et al. Community dynamics and the lower airway microbiota in stable chronic obstructive pulmonary disease, smokers and healthy non-smokers. Thorax, 2016,71(9):795-803.
doi: 10.1136/thoraxjnl-2015-207235 URL pmid: 27146202 |
[5] |
Mayhew D, Devos N, Lambert C , et al. Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations. Thorax, 2018,73(5):422-430.
doi: 10.1136/thoraxjnl-2017-210408 URL pmid: 29386298 |
[6] |
Dickson RP, Martinez FJ, Huffnagle GB . The role of the microbiome in exacerbations of chronic lung diseases. Lancet, 2014,384(9944):691-702.
doi: 10.1016/S0140-6736(14)61136-3 URL pmid: 4166502 |
[7] |
Racsa LD, Deleon-Carnes M, Hiskey M , et al. Identification of bacterial pathogens from formalin-fixed paraffin-embedded tissues by using 16S sequencing: retrospective correlation of results to clinicians’ responses. Hum Pathol, 2017,59:132-138.
doi: 10.1016/j.humpath.2016.09.015 URL pmid: 27717884 |
[8] |
Cui Z, Zhou Y, Li H , et al. Complex sputum microbial composition in patients with pulmonary tuberculosis. BMC Microbiol, 2012,12:276.
doi: 10.1186/1471-2180-12-276 URL pmid: 3541192 |
[9] |
Botero LE, Delgado-Serrano L, Cepeda ML , et al. Respiratory tract clinical sample selection for microbiota analysis in patients with pulmonary tuberculosis. Microbiome, 2014,2:29.
doi: 10.1186/2049-2618-2-29 URL pmid: 4164332 |
[10] |
Cheung MK, Lam WY, Fung WY , et al. Sputum microbiota in tuberculosis as revealed by 16S rRNA pyrosequencing. PLoS One, 2013,8(1):e54574.
doi: 10.1371/journal.pone.0054574 URL pmid: 23365674 |
[11] |
He X , McLean JS, Edlund A, et al. Cultivation of a human-associated TM7 phylotype reveals a reduced genome and epibiotic parasitic lifestyle. Proc Natl Acad Sci U S A, 2015,112(1):244-249.
doi: 10.1073/pnas.1419038112 URL pmid: 25535390 |
[12] |
Zhou Y, Lin F, Cui Z , et al. Correlation between Either Cupriavidus or Porphyromonas and Primary Pulmonary Tuberculosis Found by Analysing the Microbiota in Patients’ Bronchoalveolar Lavage Fluid. PLoS One, 2015,10(5):e124194.
doi: 10.1371/journal.pone.0124194 URL pmid: 26000957 |
[13] |
Adami AJ, Cervantes JL . The microbiome at the pulmonary alveolar niche and its role in Mycobacterium tuberculosis infection. Tuberculosis (Edinb), 2015,95(6):651-658.
doi: 10.1016/j.tube.2015.07.004 URL pmid: 26455529 |
[14] |
Wu J, Liu W, He L , et al. Sputum microbiota associated with new, recurrent and treatment failure tuberculosis. PLoS One, 2013,8(12):e83445.
doi: 10.1371/journal.pone.0083445 URL pmid: 3862690 |
[15] |
Krishna P, Jain A, Bisen PS . Microbiome diversity in the sputum of patients with pulmonary tuberculosis. Eur J Clin Microbiol Infect Dis, 2016,35(7):1205-1210.
doi: 10.1007/s10096-016-2654-4 URL pmid: 27142586 |
[16] |
Hahn A, Sanyal A, Perez GF , et al. Different next generation sequencing platforms produce different microbial profiles and diversity in cystic fibrosis sputum. J Microbiol Methods, 2016,130:95-99.
doi: 10.1016/j.mimet.2016.09.002 URL pmid: 27609714 |
[1] | Tuberculosis Control Branch of Chinese Antituberculosis Association, The Youth Branch of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Evidence-based guidelines for application of digital adherence technology in tuberculosis medication management in China [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 385-397. |
[2] | Li Jinhao, Hu Dongmei, Xu Caihong. Investigation on the willingness of tuberculosis health-care workers to implement tuberculosis preventive treatment and analysis of influencing factors [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 398-407. |
[3] | Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu. Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415. |
[4] | Jiang Xue, Bai Yunlong, Ma Jianjun, An Yuan, Yang Fan, Zhao Qinglong. Status and influencing factors of diagnosis and treatment delay of rifampicin resistant pulmonary tuberculosis patients, Jilin Province, 2020—2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 416-424. |
[5] | Wu Xuan, Zhang Yanqiu, Xu Jiying, Meng Dan, Sun Dingyong. Analysis of factors influencing the treatment outcomes of patients with pulmonary tuberculosis and diabetes mellitus in Henan Province (2019—2023) [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 425-431. |
[6] | An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui. Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438. |
[7] | Feng Wei, Zheng Hailun, Meng Weili, Luo Ping. Analysis of under-reporting before arrival of pulmonary tuberculosis patients registered and managed by Tuberculosis Prevention and Control Institutions in Xicheng District, Beijing from 2018 to 2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 439-443. |
[8] | Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui. Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453. |
[9] | Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi. Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459. |
[10] | Wang Yingchao, Liu Weiyi, Ji Xiuxiu, Shang Xuetian, Jia Hongyan, Zhang Lanyue, Sun Qi, Du Boping, Zhu Chuanzhi, Pan Liping, Zhang Zongde. Profile analysis of circRNA expression and identification of diagnostic markers in peripheral blood mononuclear cells of tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 460-470. |
[11] | Zhu Mingzhi, Shao Yanqin, Fan Dapeng, Liu Libin, Mei Bin, Dai Lingshan, Cai Long. Diagnostic value of urine lipoarabinomannan antigen detection in extrapulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 471-476. |
[12] | Hao Mingxiao, Mi Jie, Xu Zongyi. Effectiveness of a continuity of care model in patients with tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481. |
[13] | Shang Xiyu, Zhang Huifang, Cao Yuqing, Xiong Yibai, Ji Xinyu, Tian Yaxin, Li Jiajia, Wang Ni, Ma Yan. Bibliometric analysis of global research status and hotspots in the basic research of Traditional Chinese Medicine for tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 482-497. |
[14] | Qin Lili, Yang Chengqing, Mai Hongzhen, Xu Qifeng, Xue Xinying, Lu Xiwei. Advances in the clinical diagnosis and treatment of post-tuberculosis chronic pulmonary aspergillosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 498-504. |
[15] | Luo Li, Luo Linzi, Yin Quhua, Zhou Lei, Lu Zhibin, Ding Yan, Xiao Yangbao. Progress in bronchoscopic diagnosis and treatment of lymph node fistula tracheobronchial tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 505-512. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||